Patients
Physicians
Sponsors
Oncologists
About Us
News
ENG
Last updated 7 months ago
Share
A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adult Male Subjects With Cerebral Adrenoleukodystrophy
40 patients around the world
Available in
United States, Argentina, Brazil
Minoryx Therapeutics, S.L.
2
Research sites
40
Patients around the world
Requirements for the patient
From 18 Years
Male
Medical requirements
Inclusion criteria
Exclusion criteria
Sites
Hospital Universitario Austral - Pilar
View site
Av. Juan Domingo Perón 1500, Pilar, Buenos Aires
Hospital Universitario Austral - Pilar
View site
Av. Juan Domingo Perón 1500, Pilar, Buenos Aires
Universidad Federal de São Paulo - Unifesp
View site
R. Sena Madureira, 1500 - Vila Clementino, São Paulo - SP, 04021-001
Universidad Federal de São Paulo - Unifesp
View site
R. Sena Madureira, 1500 - Vila Clementino, São Paulo - SP, 04021-001
See details
Contact us
Contact us
Study
CALYX
Sponsor
Minoryx Therapeutics, S.L.
Requirements
From 18 Years
Male
Unique study ID
clinicaltrials.gov
NCT05819866
About us
Our mission
Our team
Partners
FAQs
Medical news
Latest news
Studies
Interviews
Testimonials
Products
UEPM Onco
UEPM Physicians
Links
Downloads
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent